Cantor Fitzgerald Analyst Recommendations & Stock Picks

Name: Community Performance Rating
Item: Cantor Fitzgerald
Rating: 2.7
Author: MarketBeat

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Cantor Fitzgerald. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Cantor Fitzgerald.

Company	Date	Action	Brokerage	Analyst	Rating	Price Target	Impact on Price
NNOX Nano-X Imaging	5/24/2023	Target Raised by	Cantor Fitzgerald			$21.00 -> $30.00	Low
STOK Stoke Therapeutics	5/23/2023	Target Raised by	Cantor Fitzgerald			$20.00 -> $25.00	Low
RBT Rubicon Technologies	5/23/2023	Target Lowered by	Cantor Fitzgerald			$2.60 -> $1.90	Low
ECX ECARX	5/22/2023	Initiated by	Cantor Fitzgerald	Analyst D. Soderberg	Overweight	$10.00	Low
LUNR Intuitive Machines	5/19/2023	Initiated by	Cantor Fitzgerald	Analyst A. Sheppard	Overweight	$11.00	Low
BITF Bitfarms	5/19/2023	Initiated by	Cantor Fitzgerald		Overweight	$2.00	Low

AMAM Ambrx Biopharma	5/19/2023	Initiated by	Cantor Fitzgerald	Analyst L. Chen	Overweight	$25.00	Low
PFE Pfizer	5/17/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low
MYNZ Mainz Biomed	5/18/2023	Target Lowered by	Cantor Fitzgerald			$15.00 -> $12.00	Low
NYXH Nyxoah	5/18/2023	Target Lowered by	Cantor Fitzgerald			$17.00 -> $12.00	Low
ABOS Acumen Pharmaceuticals	5/18/2023	Initiated by	Cantor Fitzgerald	Analyst P. Stavropoulos	Overweight	$13.00	Low
PRQR ProQR Therapeutics	5/17/2023	Target Lowered by	Cantor Fitzgerald	Analyst J. Kim		$5.00 -> $4.50	Low
LUCD Lucid Diagnostics	5/17/2023	Target Lowered by	Cantor Fitzgerald			$4.50 -> $4.00	Low
XNCR Xencor	5/15/2023	Reiterated by	Cantor Fitzgerald	Analyst P. Stavropoulos	Overweight		Low
VSTM Verastem	5/15/2023	Reiterated by	Cantor Fitzgerald	Analyst P. Stavropoulos	Overweight		Low
RZLT Rezolute	5/15/2023	Reiterated by	Cantor Fitzgerald	Analyst P. Stavropoulos	Overweight		Low
PLRX Pliant Therapeutics	5/15/2023	Reiterated by	Cantor Fitzgerald	Analyst P. Stavropoulos	Overweight		Low
ORTX Orchard Therapeutics	5/15/2023	Reiterated by	Cantor Fitzgerald	Analyst P. Stavropoulos	Overweight		Low
JSPR Jasper Therapeutics	5/15/2023	Reiterated by	Cantor Fitzgerald	Analyst P. Stavropoulos	Overweight		Low
IMNM Immunome	5/15/2023	Reiterated by	Cantor Fitzgerald	Analyst P. Stavropoulos	Overweight		Low
ELDN Eledon Pharmaceuticals	5/15/2023	Reiterated by	Cantor Fitzgerald	Analyst P. Stavropoulos	Overweight		Low
ARCT Arcturus Therapeutics	5/15/2023	Reiterated by	Cantor Fitzgerald	Analyst P. Stavropoulos	Overweight		Low
ANNX Annexon	5/15/2023	Reiterated by	Cantor Fitzgerald	Analyst P. Stavropoulos	Overweight		Low
CLNN Clene	5/16/2023	Target Lowered by	Cantor Fitzgerald			$5.00 -> $4.00	Low
SEEL Seelos Therapeutics	5/16/2023	Target Lowered by	Cantor Fitzgerald			$3.00 -> $2.00	Low
CBAY CymaBay Therapeutics	5/16/2023	Target Raised by	Cantor Fitzgerald			$13.00 -> $15.00	Low
FBIO Fortress Biotech	5/16/2023	Target Lowered by	Cantor Fitzgerald	Analyst J. Kim		$6.00 -> $5.00	Low
CKPT Checkpoint Therapeutics	5/16/2023	Target Lowered by	Cantor Fitzgerald			$54.00 -> $19.00	Low
OUST Ouster	5/15/2023	Reiterated by	Cantor Fitzgerald	Analyst A. Sheppard	Overweight		Low
AGIL AgileThought	5/15/2023	Downgraded by	Cantor Fitzgerald		Overweight -> Neutral		Low
HL Hecla Mining	5/12/2023	Downgraded by	Cantor Fitzgerald		Buy -> Hold		Low
AZYO Aziyo Biologics	5/12/2023	Target Lowered by	Cantor Fitzgerald			$12.00 -> $10.00	Low
VYNE VYNE Therapeutics	5/12/2023	Target Raised by	Cantor Fitzgerald			$5.00 -> $9.00	Low
SOUN SoundHound AI	5/12/2023	Target Lowered by	Cantor Fitzgerald			$3.20 -> $2.80	Low
ASXC Asensus Surgical	5/12/2023	Target Lowered by	Cantor Fitzgerald			$1.50 -> $1.30	N/A
PSNY Polestar Automotive Holding UK	5/12/2023	Target Lowered by	Cantor Fitzgerald	Analyst A. Sheppard		$7.00 -> $6.00	Low
IREN Iris Energy	5/12/2023	Upgraded by	Cantor Fitzgerald		Neutral -> Overweight	$4.00 -> $7.00	Low
SMRT SmartRent	5/11/2023	Target Raised by	Cantor Fitzgerald			$4.00 -> $5.00	Low
NXT Nextracker	5/11/2023	Target Raised by	Cantor Fitzgerald	Analyst D. Soderberg		$40.00 -> $44.00	Low
MVIS MicroVision	5/11/2023	Target Lowered by	Cantor Fitzgerald			$5.00 -> $4.00	Low

LBPH Longboard Pharmaceuticals	5/11/2023	Target Raised by	Cantor Fitzgerald			$11.00 -> $16.00	Low
HYLN Hyliion	5/11/2023	Target Lowered by	Cantor Fitzgerald			$4.00 -> $3.00	Low
AVPT AvePoint	5/11/2023	Target Raised by	Cantor Fitzgerald			$7.00 -> $8.00	Low
PRCH Porch Group	5/8/2023	Reiterated by	Cantor Fitzgerald	Analyst J. Siegler	Overweight		Low
RETA Reata Pharmaceuticals	5/10/2023	Target Lowered by	Cantor Fitzgerald			$138.00 -> $110.00	Low
ML MoneyLion	5/10/2023	Target Raised by	Cantor Fitzgerald			$3.00 -> $30.00	Low
CUTR Cutera	5/10/2023	Target Lowered by	Cantor Fitzgerald			$33.00 -> $21.00	Low
ARRY Array Technologies	5/10/2023	Target Lowered by	Cantor Fitzgerald	Analyst D. Soderberg		$26.00 -> $24.00	N/A
LVOX LiveVox	5/10/2023	Target Raised by	Cantor Fitzgerald			$2.60 -> $3.00	Low
AVTA Avantax	5/9/2023	Target Lowered by	Cantor Fitzgerald			$33.00 -> $29.00	Low
CRVS Corvus Pharmaceuticals	5/9/2023	Target Raised by	Cantor Fitzgerald			$2.00 -> $4.00	Low
PGNY Progyny	5/9/2023	Target Raised by	Cantor Fitzgerald			$44.00 -> $45.00	Low
SHLS Shoals Technologies Group	5/9/2023	Target Lowered by	Cantor Fitzgerald	Analyst D. Soderberg		$30.00 -> $27.00	Low
LCID Lucid Group	5/9/2023	Target Lowered by	Cantor Fitzgerald			$13.00 -> $10.00	Low
PRTA Prothena	5/8/2023	Target Raised by	Cantor Fitzgerald			$98.00 -> $120.00	Low
ITCI Intra-Cellular Therapies	5/5/2023	Target Raised by	Cantor Fitzgerald			$87.00 -> $90.00	Low
GDYN Grid Dynamics	5/5/2023	Target Lowered by	Cantor Fitzgerald			$20.00 -> $17.00	Low
CLDX Celldex Therapeutics	5/5/2023	Target Lowered by	Cantor Fitzgerald			$55.00 -> $54.00	Low
ETNB 89bio	5/5/2023	Target Raised by	Cantor Fitzgerald	Analyst K. Kluska		$40.00 -> $41.00	Low
FTNT Fortinet	5/5/2023	Target Raised by	Cantor Fitzgerald			$70.00 -> $75.00	Low
LICY Li-Cycle	5/4/2023	Initiated by	Cantor Fitzgerald		Buy		Low
FATE Fate Therapeutics	5/4/2023	Target Lowered by	Cantor Fitzgerald	Analyst L. Watsek		$8.00 -> $5.00	Low
UDMY Udemy	5/4/2023	Target Lowered by	Cantor Fitzgerald			$18.00 -> $16.00	Low
SPT Sprout Social	5/3/2023	Target Lowered by	Cantor Fitzgerald			$52.00 -> $46.00	Low
SRPT Sarepta Therapeutics	5/3/2023	Target Lowered by	Cantor Fitzgerald			$165.00 -> $158.00	Low
PACB Pacific Biosciences of California	5/3/2023	Target Raised by	Cantor Fitzgerald	Analyst R. Osborn		$12.00 -> $13.00	Low
HRMY Harmony Biosciences	5/3/2023	Target Raised by	Cantor Fitzgerald			$71.00 -> $75.00	Low
OXBDF Oxford Biomedica	5/3/2023	Initiated by	Cantor Fitzgerald		Overweight		Low
PLRX Pliant Therapeutics	5/1/2023	Target Raised by	Cantor Fitzgerald			$52.00 -> $63.00	Low
LLY Eli Lilly and	4/28/2023	Target Raised by	Cantor Fitzgerald			$432.00 -> $485.00	Low
COUR Coursera	4/28/2023	Target Lowered by	Cantor Fitzgerald			$14.00 -> $13.00	Low
NET Cloudflare	4/28/2023	Target Lowered by	Cantor Fitzgerald			$65.00 -> $50.00	Low
ASND Ascendis Pharma A/S	4/28/2023	Target Raised by	Cantor Fitzgerald			$142.00 -> $152.00	Low
IRON Disc Medicine Opco	4/28/2023	Initiated by	Cantor Fitzgerald	Analyst K. Kluska	Overweight	$45.00	Low
TWOU 2U	4/27/2023	Upgraded by	Cantor Fitzgerald		Neutral -> Overweight	$7.40	Low
PSNY Polestar Automotive Holding UK	4/27/2023	Initiated by	Cantor Fitzgerald	Analyst A. Sheppard	Overweight	$7.00	Low
RARE Ultragenyx Pharmaceutical	4/26/2023	Initiated by	Cantor Fitzgerald	Analyst K. Kluska	Overweight	$114.00	Low
ZFOX ZeroFox	4/25/2023	Initiated by	Cantor Fitzgerald	Analyst J. Ruykhaver	Overweight	$3.00	Low
XENE Xenon Pharmaceuticals	4/25/2023	Initiated by	Cantor Fitzgerald	Analyst C. Duncan	Overweight	$58.00	Low
HUM Humana	4/20/2023	Initiated by	Cantor Fitzgerald	Analyst S. James	Overweight	$597.00	Low
UNH UnitedHealth Group	4/20/2023	Initiated by	Cantor Fitzgerald	Analyst S. James	Overweight	$591.00	Low
CNC Centene	4/20/2023	Initiated by	Cantor Fitzgerald	Analyst S. James	Overweight	$80.00	Low
SGRY Surgery Partners	4/20/2023	Initiated by	Cantor Fitzgerald		Overweight	$43.00	Low
THC Tenet Healthcare	4/20/2023	Initiated by	Cantor Fitzgerald		Overweight	$73.00	Low
MOH Molina Healthcare	4/20/2023	Initiated by	Cantor Fitzgerald	Analyst S. James	Overweight	$354.00	Low
HCA HCA Healthcare	4/20/2023	Initiated by	Cantor Fitzgerald		Overweight	$304.00	Low
ELV Elevance Health	4/20/2023	Initiated by	Cantor Fitzgerald	Analyst S. James	Overweight	$547.00	Low
CI The Cigna Group	4/20/2023	Initiated by	Cantor Fitzgerald	Analyst S. James	Neutral	$285.00	Low
ACHC Acadia Healthcare	4/20/2023	Initiated by	Cantor Fitzgerald		Neutral	$83.00	Low
PGNY Progyny	4/20/2023	Initiated by	Cantor Fitzgerald		Overweight	$44.00	Low

DCGO DocGo	4/20/2023	Initiated by	Cantor Fitzgerald		Overweight	$11.00	Low
AMED Amedisys	4/20/2023	Initiated by	Cantor Fitzgerald		Neutral	$87.00	Low
CVS CVS Health	4/20/2023	Initiated by	Cantor Fitzgerald	Analyst S. James	Overweight	$87.00	Low
UHS Universal Health Services	4/20/2023	Initiated by	Cantor Fitzgerald		Underweight	$143.00	Low
RGLD Royal Gold	4/20/2023	Downgraded by	Cantor Fitzgerald		Buy -> Hold		Low
SYM Symbotic	4/20/2023	Target Raised by	Cantor Fitzgerald		Overweight	$24.00 -> $35.00	Low
TGTX TG Therapeutics	4/17/2023	Reiterated by	Cantor Fitzgerald		Overweight	$24.00	N/A
CRSP CRISPR Therapeutics	4/13/2023	Initiated by	Cantor Fitzgerald	Analyst O. Brayer	Overweight	$72.00	Low
KALV KalVista Pharmaceuticals	4/11/2023	Reiterated by	Cantor Fitzgerald	Analyst C. Duncan	Overweight		Low
ONCT Oncternal Therapeutics	4/6/2023	Downgraded by	Cantor Fitzgerald	Analyst L. Watsek	Overweight -> Neutral		Low
FENC Fennec Pharmaceuticals	4/6/2023	Target Raised by	Cantor Fitzgerald	Analyst C. Duncan	Overweight	$12.00 -> $16.00	Low
ZYNE Zynerba Pharmaceuticals	3/31/2023	Reiterated by	Cantor Fitzgerald	Analyst C. Duncan	Overweight		Low
SPRO Spero Therapeutics	3/31/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low
FBIO Fortress Biotech	4/3/2023	Reiterated by	Cantor Fitzgerald	Analyst J. Kim	Overweight		Low
ONCT Oncternal Therapeutics	4/4/2023	Target Lowered by	Cantor Fitzgerald	Analyst L. Watsek	Overweight	$4.00 -> $1.30	Low
BHVN Biohaven	4/4/2023	Target Raised by	Cantor Fitzgerald	Analyst C. Duncan	Overweight	$27.00 -> $31.00	Low
ATNM Actinium Pharmaceuticals	4/4/2023	Target Raised by	Cantor Fitzgerald			$26.00 -> $27.00	N/A
CSGS CSG Systems International	4/4/2023	Initiated by	Cantor Fitzgerald	Analyst B. Knoblauch	Overweight		Low
CYTK Cytokinetics	4/3/2023	Target Lowered by	Cantor Fitzgerald		Overweight	$61.00 -> $59.00	Low
EVGO EVgo	3/31/2023	Reiterated by	Cantor Fitzgerald		Overweight	$10.00	Low
NOVN Novan	3/31/2023	Reiterated by	Cantor Fitzgerald		Overweight	$8.00	Low
TSHA Taysha Gene Therapies	3/30/2023	Target Lowered by	Cantor Fitzgerald	Analyst K. Kluska	Overweight	$13.00 -> $2.00	Low
ITCI Intra-Cellular Therapies	3/29/2023	Target Raised by	Cantor Fitzgerald		Overweight	$83.00 -> $87.00	Low
ORTX Orchard Therapeutics	3/28/2023	Target Raised by	Cantor Fitzgerald	Analyst P. Stavropoulos	Overweight	$15.00	Low
RETA Reata Pharmaceuticals	3/27/2023	Target Raised by	Cantor Fitzgerald		Overweight	$121.00 -> $138.00	Low
OUST Ouster	3/24/2023	Target Lowered by	Cantor Fitzgerald			$50.00 -> $30.00	Low
ETNB 89bio	3/22/2023	Target Raised by	Cantor Fitzgerald	Analyst K. Kluska		$34.00 -> $45.00	N/A
TWOU 2U	3/22/2023	Reiterated by	Cantor Fitzgerald		Neutral	$9.50	Low
XFOR X4 Pharmaceuticals	3/22/2023	Reiterated by	Cantor Fitzgerald	Analyst K. Kluska	Overweight	$3.00	Low
SRPT Sarepta Therapeutics	3/17/2023	Target Lowered by	Cantor Fitzgerald			$178.00 -> $165.00	Low
CPRX Catalyst Pharmaceuticals	3/17/2023	Target Raised by	Cantor Fitzgerald			$22.00 -> $25.00	Low
GLTO Galecto	3/17/2023	Initiated by	Cantor Fitzgerald	Analyst K. Kluska	Overweight	$16.00	Low
REE REE Automotive	3/16/2023	Downgraded by	Cantor Fitzgerald	Analyst A. Sheppard	Overweight -> Neutral	$2.00 -> $1.00	Low
EVLO Evelo Biosciences	3/16/2023	Downgraded by	Cantor Fitzgerald	Analyst K. Kluska	Overweight -> Neutral		Low
RAPT RAPT Therapeutics	3/15/2023	Target Lowered by	Cantor Fitzgerald			$44.00 -> $40.00	Low
ANNX Annexon	3/14/2023	Target Lowered by	Cantor Fitzgerald		Overweight	$22.00 -> $18.00	Low
ACAD ACADIA Pharmaceuticals	3/14/2023	Target Raised by	Cantor Fitzgerald		Overweight	$28.00 -> $33.00	Low
CIFR Cipher Mining	3/13/2023	Initiated by	Cantor Fitzgerald		Buy	$3.00	Low
VFF Village Farms International	3/10/2023	Target Lowered by	Cantor Fitzgerald		Overweight	$7.25 -> $4.15	Low
ENVX Enovix	3/10/2023	Reiterated by	Cantor Fitzgerald	Analyst D. Soderberg	Overweight	$25.00	N/A
CLNN Clene	3/10/2023	Target Raised by	Cantor Fitzgerald		Buy	$6.00 -> $8.00	Low
BNOX Bionomics	3/10/2023	Target Lowered by	Cantor Fitzgerald			$10.00 -> $8.00	Low
SMRT SmartRent	3/9/2023	Target Lowered by	Cantor Fitzgerald		Overweight	$4.25 -> $4.00	Low
JSPR Jasper Therapeutics	3/9/2023	Reiterated by	Cantor Fitzgerald		Overweight	$6.00	Low
SOUN SoundHound AI	3/8/2023	Target Raised by	Cantor Fitzgerald			$1.60 -> $3.20	Low
DRRX DURECT	3/8/2023	Target Raised by	Cantor Fitzgerald			$37.00 -> $44.00	Low
STOK Stoke Therapeutics	3/7/2023	Reiterated by	Cantor Fitzgerald		Overweight	$20.00	N/A
CYTK Cytokinetics	3/7/2023	Reiterated by	Cantor Fitzgerald		Overweight	$61.00	N/A
ALLK Allakos	3/7/2023	Reiterated by	Cantor Fitzgerald		Overweight	$7.00	N/A
CDTX Cidara Therapeutics	3/8/2023	Reiterated by	Cantor Fitzgerald		Overweight	$5.00	Low

MRNS Marinus Pharmaceuticals	3/8/2023	Reiterated by	Cantor Fitzgerald		Overweight	$28.00	Low
KRTX Karuna Therapeutics	3/7/2023	Initiated by	Cantor Fitzgerald	Analyst C. Duncan	Neutral	$214.00	Low
ONC Oncolytics Biotech	3/6/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight	C$9.00	N/A
MLTX MoonLake Immunotherapeutics	3/6/2023	Reiterated by	Cantor Fitzgerald	Analyst P. Agrawal	Overweight	$23.00	Low
ETNB 89bio	3/6/2023	Reiterated by	Cantor Fitzgerald	Analyst K. Kluska	Overweight	$34.00	Low
RIOT Riot Platforms	3/6/2023	Reiterated by	Cantor Fitzgerald		Overweight	$10.00	N/A
ONCY Oncolytics Biotech	3/6/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low
ZS Zscaler	3/3/2023	Target Lowered by	Cantor Fitzgerald	Analyst J. Ruykhaver		$160.00 -> $140.00	Low
NXT Nextracker	3/3/2023	Initiated by	Cantor Fitzgerald	Analyst D. Soderberg	Overweight	$40.00	Low
HCM HUTCHMED	3/1/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low
ARQT Arcutis Biotherapeutics	3/1/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low
RIVN Rivian Automotive	3/1/2023	Target Lowered by	Cantor Fitzgerald		Overweight	$30.00 -> $27.00	Low
RETA Reata Pharmaceuticals	3/1/2023	Target Raised by	Cantor Fitzgerald		Overweight	$61.00 -> $121.00	N/A
NRDY Nerdy	3/1/2023	Target Raised by	Cantor Fitzgerald		Overweight	$4.00 -> $6.00	Low
GTBIF Green Thumb Industries	3/1/2023	Target Lowered by	Cantor Fitzgerald		Overweight	$32.00 -> $30.00	Low
BCYC Bicycle Therapeutics	2/27/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Watsek	Overweight	$74.00	Low
ALLK Allakos	2/27/2023	Reiterated by	Cantor Fitzgerald		Overweight	$7.00	Low
SIBN SI-BONE	2/28/2023	Target Raised by	Cantor Fitzgerald	Analyst R. Osborn	Overweight	$22.00 -> $24.00	Low
CRLBF Cresco Labs	2/24/2023	Reiterated by	Cantor Fitzgerald		Overweight	$14.25	Low
INSM Insmed	2/24/2023	Target Lowered by	Cantor Fitzgerald		Overweight	$49.00 -> $46.00	Low
ROOT Root	2/23/2023	Downgraded by	Cantor Fitzgerald	Analyst J. Siegler	Overweight -> Neutral	$22.00 -> $6.00	Low
GRPH Graphite Bio	2/23/2023	Downgraded by	Cantor Fitzgerald	Analyst O. Brayer	Overweight -> Neutral	$8.00 -> $3.00	Low
PWSC PowerSchool	2/23/2023	Target Raised by	Cantor Fitzgerald		Overweight	$21.00 -> $27.00	Low
LCID Lucid Group	2/23/2023	Target Lowered by	Cantor Fitzgerald	Analyst R. Department	Overweight	$18.00 -> $13.00	Low
PTCT PTC Therapeutics	2/22/2023	Target Lowered by	Cantor Fitzgerald		Overweight	$68.00 -> $66.00	Low
CGC Canopy Growth	2/17/2023	Target Lowered by	Cantor Fitzgerald		Neutral	$3.30 -> $3.20	N/A
EVEX EVE	2/16/2023	Initiated by	Cantor Fitzgerald	Analyst A. Sheppard	Neutral	$7.00	Low
UDMY Udemy	2/15/2023	Target Lowered by	Cantor Fitzgerald		Overweight	$20.00 -> $18.00	Low
IMVT Immunovant	2/15/2023	Initiated by	Cantor Fitzgerald	Analyst L. Chen	Overweight	$30.00	Low
MLTX MoonLake Immunotherapeutics	2/14/2023	Initiated by	Cantor Fitzgerald	Analyst P. Agrawal	Overweight	$23.00	Low
SPT Sprout Social	2/13/2023	Downgraded by	Cantor Fitzgerald		Overweight -> Neutral	$62.00 -> $53.00	Low
VRNOF Verano	2/10/2023	Initiated by	Cantor Fitzgerald		Overweight	$10.00	Low
NET Cloudflare	2/10/2023	Target Raised by	Cantor Fitzgerald			$55.00 -> $65.00	Low
AAWH Ascend Wellness	2/10/2023	Initiated by	Cantor Fitzgerald		Neutral		N/A
COUR Coursera	2/10/2023	Downgraded by	Cantor Fitzgerald		Overweight -> Neutral	$17.00 -> $16.00	Low
TGTX TG Therapeutics	2/7/2023	Target Raised by	Cantor Fitzgerald		Overweight	$18.00 -> $24.00	Low
RIOT Riot Platforms	2/7/2023	Reiterated by	Cantor Fitzgerald		Overweight	$10.00	N/A
ACRS Aclaris Therapeutics	2/7/2023	Reiterated by	Cantor Fitzgerald		Overweight	$38.00	Low
NBIX Neurocrine Biosciences	2/7/2023	Target Lowered by	Cantor Fitzgerald		Overweight	$132.00 -> $127.00	Low
JSPR Jasper Therapeutics	2/7/2023	Target Lowered by	Cantor Fitzgerald		Overweight	$10.00 -> $6.00	Low
OTLK Outlook Therapeutics	2/6/2023	Initiated by	Cantor Fitzgerald	Analyst K. Kluska	Overweight	$4.00	Low
DGII Digi International	2/3/2023	Reiterated by	Cantor Fitzgerald	Analyst D. Soderberg	Overweight	$48.00	Low
TWOU 2U	2/3/2023	Reiterated by	Cantor Fitzgerald		Neutral	$8.00 -> $9.50	Low
SPPI Spectrum Pharmaceuticals	2/3/2023	Target Lowered by	Cantor Fitzgerald		Neutral	$3.00 -> $0.75	Low
MESO Mesoblast	2/1/2023	Reiterated by	Cantor Fitzgerald		Overweight	$23.00	Low
TSHA Taysha Gene Therapies	2/1/2023	Reiterated by	Cantor Fitzgerald	Analyst K. Kluska	Overweight	$24.00 -> $13.00	Low
PSTX Poseida Therapeutics	2/1/2023	Reiterated by	Cantor Fitzgerald		Overweight	$24.00	Low
JNJ Johnson & Johnson	2/1/2023	Reiterated by	Cantor Fitzgerald		Overweight	$215.00	Low
PFE Pfizer	2/1/2023	Reiterated by	Cantor Fitzgerald		Overweight	$75.00	Low
ITCI Intra-Cellular Therapies	2/1/2023	Reiterated by	Cantor Fitzgerald		Overweight	$83.00	Low

ARVN Arvinas	1/31/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Watsek	Overweight	$90.00	Low
VERV Verve Therapeutics	2/1/2023	Initiated by	Cantor Fitzgerald	Analyst R. Bienkowski	Neutral	$21.00	Low
BEAM Beam Therapeutics	1/31/2023	Initiated by	Cantor Fitzgerald	Analyst R. Bienkowski	Overweight	$62.00	Low
NTLA Intellia Therapeutics	1/31/2023	Initiated by	Cantor Fitzgerald	Analyst R. Bienkowski	Overweight	$67.00	Low
EDIT Editas Medicine	1/31/2023	Initiated by	Cantor Fitzgerald	Analyst R. Bienkowski	Overweight	$15.00	Low
CBAY CymaBay Therapeutics	1/31/2023	Target Raised by	Cantor Fitzgerald		Overweight	$10.00 -> $13.00	Low
PGEN Precigen	1/30/2023	Target Raised by	Cantor Fitzgerald		Overweight	$7.00 -> $10.00	Low
FROG JFrog	1/25/2023	Initiated by	Cantor Fitzgerald	Analyst J. Ruykhaver	Overweight	$29.00	Low
DDOG Datadog	1/25/2023	Initiated by	Cantor Fitzgerald	Analyst J. Ruykhaver	Overweight	$95.00	Low
SHLS Shoals Technologies Group	1/25/2023	Initiated by	Cantor Fitzgerald	Analyst D. Soderberg	Neutral	$30.00	Low
CXM Sprinklr	1/24/2023	Initiated by	Cantor Fitzgerald		Overweight	$12.00	Low
FRSH Freshworks	1/24/2023	Initiated by	Cantor Fitzgerald		Overweight	$18.00	Low
PLRX Pliant Therapeutics	1/23/2023	Target Raised by	Cantor Fitzgerald		Overweight	$40.00 -> $52.00	Low
PAVM PAVmed	1/20/2023	Downgraded by	Cantor Fitzgerald	Analyst R. Osborn	Overweight -> Neutral	$4.00 -> $1.50	Low
AWH Aspira Women's Health	1/20/2023	Downgraded by	Cantor Fitzgerald	Analyst R. Osborn	Overweight -> Neutral	$45.00 -> $30.00	Low
AWH Aspira Women's Health	1/20/2023	Downgraded by	Cantor Fitzgerald	Analyst R. Osborn	Overweight -> Neutral	$45.00 -> $30.00	Low
PACB Pacific Biosciences of California	1/20/2023	Downgraded by	Cantor Fitzgerald	Analyst R. Osborn	Overweight -> Neutral	$12.00	Low
PRE Prenetics Global	1/18/2023	Initiated by	Cantor Fitzgerald	Analyst R. Osborn	Overweight	$7.00	Low
BMY Bristol-Myers Squibb	1/17/2023	Initiated by	Cantor Fitzgerald	Analyst O. Brayer	Overweight	$95.00	Low
ORMP Oramed Pharmaceuticals	1/13/2023	Downgraded by	Cantor Fitzgerald	Analyst C. Duncan	Overweight -> Neutral		Low
TXMD TherapeuticsMD	1/11/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Neutral -> Neutral		Low
HGEN Humanigen	1/11/2023	Initiated by	Cantor Fitzgerald	Analyst L. Chen	Neutral -> Neutral		Low
CUTR Cutera	1/11/2023	Downgraded by	Cantor Fitzgerald		Overweight -> Neutral	$85.00 -> $33.00	Low
FATE Fate Therapeutics	1/9/2023	Downgraded by	Cantor Fitzgerald	Analyst L. Watsek	Overweight -> Neutral		Low
SSIC Silver Spike Investment	1/6/2023	Initiated by	Cantor Fitzgerald	Analyst P. Zuanic	Overweight	$15.30	Low
NNOX Nano-X Imaging	1/5/2023	Initiated by	Cantor Fitzgerald		Overweight	$21.00	Low
CURLF Curaleaf	12/30/2022	Target Lowered by	Cantor Fitzgerald		Overweight	$13.00 -> $12.00	Low
CRLBF Cresco Labs	12/30/2022	Target Lowered by	Cantor Fitzgerald		Overweight	$15.00 -> $14.25	Low
ARDX Ardelyx	12/29/2022	Target Raised by	Cantor Fitzgerald			$1.60 -> $3.00	Low
TSHA Taysha Gene Therapies	12/21/2022	Reiterated by	Cantor Fitzgerald	Analyst K. Kluska	Overweight		N/A
PAGS PagSeguro Digital	12/23/2022	Target Lowered by	Cantor Fitzgerald		Overweight	$20.00 -> $14.00	Low
ARRY Array Technologies	12/23/2022	Initiated by	Cantor Fitzgerald	Analyst D. Soderberg	Overweight	$26.00	N/A
PRQR ProQR Therapeutics	12/22/2022	Upgraded by	Cantor Fitzgerald	Analyst J. Kim	Neutral -> Overweight	$5.00	Low
ONCT Oncternal Therapeutics	12/22/2022	Initiated by	Cantor Fitzgerald	Analyst L. Watsek	Overweight	$4.00	Low
XFOR X4 Pharmaceuticals	12/22/2022	Initiated by	Cantor Fitzgerald	Analyst K. Kluska	Overweight	$3.00	Low
ISPO Inspirato	12/21/2022	Target Lowered by	Cantor Fitzgerald	Analyst B. Knoblauch	Overweight	$8.00 -> $5.00	Low
PRTA Prothena	12/21/2022	Target Raised by	Cantor Fitzgerald		Overweight	$91.00 -> $98.00	Low
CERE Cerevel Therapeutics	12/20/2022	Target Raised by	Cantor Fitzgerald	Analyst C. Duncan		$41.00 -> $46.00	Low
RIVN Rivian Automotive	12/20/2022	Initiated by	Cantor Fitzgerald		Overweight	$22.00	Low
MRK Merck & Co., Inc.	12/19/2022	Target Raised by	Cantor Fitzgerald		Overweight	$120.00 -> $135.00	Low
SRPT Sarepta Therapeutics	12/13/2022	Target Raised by	Cantor Fitzgerald			$150.00 -> $174.00	Low
CLSK CleanSpark	12/9/2022	Initiated by	Cantor Fitzgerald		Overweight	$5.00	Low
CERS Cerus	12/5/2022	Reiterated by	Cantor Fitzgerald	Analyst B. Folkes	Overweight		Low
AVXL Anavex Life Sciences	12/6/2022	Downgraded by	Cantor Fitzgerald	Analyst C. Duncan	Overweight -> Neutral	$16.00 -> $11.00	Low
PRTG Portage Biotech	11/30/2022	Target Lowered by	Cantor Fitzgerald	Analyst L. Watsek		$26.00 -> $18.00	Low
CRWD CrowdStrike	11/30/2022	Target Lowered by	Cantor Fitzgerald			$240.00 -> $160.00	Low
SOUN SoundHound AI	11/30/2022	Upgraded by	Cantor Fitzgerald		Neutral -> Overweight		Low
SNDL SNDL	11/28/2022	Target Raised by	Cantor Fitzgerald		Neutral	$3.56 -> $3.60	Low
JUSHF Jushi	11/23/2022	Target Raised by	Cantor Fitzgerald		Neutral	$2.25 -> $2.35	Low
PAGS PagSeguro Digital	11/23/2022	Target Lowered by	Cantor Fitzgerald			$25.00 -> $20.00	Low
ARVN Arvinas	11/23/2022	Target Lowered by	Cantor Fitzgerald	Analyst L. Watsek		$106.00 -> $90.00	Low
FRX Fennec Pharmaceuticals	11/22/2022	Upgraded by	Cantor Fitzgerald	Analyst C. Duncan	Neutral -> Overweight		N/A
FENC Fennec Pharmaceuticals	11/21/2022	Upgraded by	Cantor Fitzgerald	Analyst C. Duncan	Neutral -> Overweight	$9.00 -> $12.00	Low
TH Theratechnologies	11/17/2022	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		N/A
PGEN Precigen	11/18/2022	Initiated by	Cantor Fitzgerald		Overweight	$7.00	Low
SIBN SI-BONE	11/16/2022	Reiterated by	Cantor Fitzgerald	Analyst R. Osborn	Overweight		Low
KDNY Chinook Therapeutics	11/17/2022	Reiterated by	Cantor Fitzgerald	Analyst C. Duncan	Overweight		Low
SMWB Similarweb	11/17/2022	Target Lowered by	Cantor Fitzgerald		Overweight	$20.00 -> $13.00	Low
THTX Theratechnologies	11/17/2022	Initiated by	Cantor Fitzgerald	Analyst L. Chen	Overweight	$9.00	Low
PHGE BiomX	11/10/2022	Reiterated by	Cantor Fitzgerald	Analyst K. Kluska	Overweight		N/A

MarketBeat Community Rating for Cantor Fitzgerald

Community Ranking:		2.7 out of 5 ( 2.7 of 5 stars)
Outperform Votes:		20,347 (Vote Outperform)
Underperform Votes:		16,979 (Vote Underperform)
Total Votes:		37,326

MarketBeat's community ratings are surveys of what our community members think about Cantor Fitzgerald and other research firms. Vote "Outperform" if you believe Cantor Fitzgerald's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Cantor Fitzgerald's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Ratings Reports and Tools

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Ratings for Popular Stocks:

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Cantor Fitzgerald Analyst Recommendations & Stock Picks

MarketBeat Community Rating for Cantor Fitzgerald

Stock Ratings Reports and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info